Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower) header
Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower) profile picture

Arun Rajasekaran, MD, FACP, FASN, FNKF

@Nephronpower

Nephrologist @RMANewMexico. GN aficionado. Principal Investigator. Clinical Trialist

 Albuquerque, NM
renalmed.com
Joined February 2017
  • Tweets2.2K
  • Following568
  • Followers1.5K
92Media
Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)Photo by Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Sara Almutar (@s_almutar) profile picture
Sara Almutar
@s_almutarNov 1
Always a pleasure catching up with the @GlomCon family!! #kidneywk
Image from Sara Almutar (@s_almutar)
Image from Sara Almutar (@s_almutar)
Image from Sara Almutar (@s_almutar)
2
20
1,954
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
UAB Nephrology (@UAB_NRTC) profile picture
UAB Nephrology@UAB_NRTCOct 30
Dr. Dana Rizk presented an oral abstract of a NEJM article on a landmark randomized control trial in IgA nephropathy in the plenary session of the American Society of Nephrology's (ASN) Kidney Week on Oct. 22. 🎉Read more: nejm.org/doi/full/10.1056/NE…
Image from UAB Nephrology (@UAB_NRTC)
7
25
1,076
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
glomcon (@GlomCon) profile picture
glomcon
@GlomConOct 27
How low is low enough? New research explores the relationship between proteinuria levels and long-term kidney survival in immunoglobulin A nephropathy (IgAN), highlighting the importance of even very low proteinuria levels. 📅 Published October 8, 2026 🔗 Read the abstract: bit.ly/4hUzRjf #GlomCon #Nephrology #KidneyResearch #RareKidneyDiseases #IgAN
Image from glomcon (@GlomCon)
17
1
43
4,151
With Dr. Bruce Julian, a legend in the field of IgA Nephropathy. So glad to have been mentored by him and @DanaRizk1 at @UAB_NRTC.
Image from Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)
1
25
549
Catching up with @DanaRizk1 @VineetaKumar8 at ASN 2026 conference @UAB_NRTC – at Denver, CO
Image from Arun Rajasekaran, MD, FACP, FASN, FNKF (@Nephronpower)
3
1
38
1,155
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Ladan Zand (@LadanZand) profile picture
Ladan Zand@LadanZandOct 24
Recording starting soon! Will discuss the latest in the field of MN from ASN Kidney week.
Image from Ladan Zand (@LadanZand)
4
49
965
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Kartik Kalra MD,FNKF,FASN (@kkalra_22) profile picture
Kartik Kalra MD,FNKF,FASN
@kkalra_22Oct 22
Excited to be part of the BRIDGE-IgAN Registry and contribute to this multicenter collaboration advancing real-world research in IgA nephropathy! 🫘🔬 Thank you @GeorgeVasquezR2 for the collaboration and for including me in this exciting initiative. It is great to see investigators across institutions coming together to better understand IgAN and ultimately improve patient care. Proud to see our collaborative work at ASN Kidney Week 2026! 🤝 @Nephronpower @ASNKidney #IgAN #KidneyWk #Nephrology #GlomerularDisease #ClinicalResearch #Collaboration
Image from Kartik Kalra MD,FNKF,FASN (@kkalra_22)
Image from Kartik Kalra MD,FNKF,FASN (@kkalra_22)
1
2
11
604
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
glomcon (@GlomCon) profile picture
glomcon
@GlomConOct 20
Centers of Excellence: Two new publications. One shared vision. GlomCon × ISGD! Two consensus papers in Kidney International and Kidney International Reports mark an important step toward unifying glomerular disease care, research, education, and global access. A unified global certification program is in development. More soon! Read the papers here: sciencedirect.com/science/ar… sciencedirect.com/science/ar…
4
10
1,428
Our comprehensive, thorough, and up-to-date review on B-Cell modulation in Immunoglobulin A Nephropathy is out. @DanaRizk1 @UAB_NRTC @RMANewMexico frontiersin.org/journals/imm…
Frontiers | B-cell modulators in immunoglobulin A nephropathy

Frontiers | B-cell modulators in immunoglobulin A nephropathy

Immunoglobulin A nephropathy (IgAN), defined by mesangial immune-complex deposition enriched for galactose-deficient IgA1 (Gd-IgA1), is the most prevalent bi...

frontiersin.org
3
1
9
529
We discuss the preclinical, translational, and clinical utilization of drugs affecting the B-Cell pathway in IgAN, including targeting the mucosal immunity, BAFF-APRIL axis, plasma-cell and CD-38 targeting, and other B-Cell signaling pathways.
1
2
112
We also focus on the latest and detailed therapeutic treatment landscape in this disease space. Great collaboration with Jan Novak, PhD and @DanaRizk1 .
1
65
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Fernando Fervenza (@fervenzaf) profile picture
Fernando Fervenza@fervenzafOct 3
Professor Roccatello giving a State of the Art lecture on Cryoglobulins.
Image from Fernando Fervenza (@fervenzaf)
Image from Fernando Fervenza (@fervenzaf)
13
41
1,298
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Fernando Fervenza (@fervenzaf) profile picture
Fernando Fervenza@fervenzafOct 3
Dr. Glassock presenting on treatment of primary podocytopaties at the Mayo GNs Course.
Image from Fernando Fervenza (@fervenzaf)
Image from Fernando Fervenza (@fervenzaf)
9
60
1,388
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Edgar V. Lerma 🇵🇭 (@edgarvlermamd) profile picture
Edgar V. Lerma 🇵🇭
@edgarvlermamdSep 26
Targeting B cells in immune-mediated kidney diseases: conclusions from @goKDIGO Controversies Conference ca. 2026 #Nephpearls #RKDSummit 👉🏼 pubmed.ncbi.nlm.nih.gov/4203…
Image from Edgar V. Lerma 🇵🇭 (@edgarvlermamd)
Image from Edgar V. Lerma 🇵🇭 (@edgarvlermamd)
Image from Edgar V. Lerma 🇵🇭 (@edgarvlermamd)
Image from Edgar V. Lerma 🇵🇭 (@edgarvlermamd)
2
24
1
59
3,974
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Sayna Norouzi, MD, FASN (@SaynaNorouzi) profile picture
Sayna Norouzi, MD, FASN
@SaynaNorouziSep 18
This year's #PKD session at #GlomConHawaii was a success; so much energy in the room, so many people wanting to get involved. Quick heads up: PKD-MDP applications close tomorrow. @GlomCon @fouadchebib @pranavgarimella @ndahl48 glomcon.org/pkdmd-program
Image from Sayna Norouzi, MD, FASN (@SaynaNorouzi)
7
34
1,826
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Edgar V. Lerma 🇵🇭 (@edgarvlermamd) profile picture
Edgar V. Lerma 🇵🇭
@edgarvlermamdSep 26
Current advances in the field and their effects on diagnostic and therapeutic algorithms open the path towards personalized use of traditional treatments and newly available drugs, which should improve outcomes and quality of life for patients with #podocytopathies (from lecture of @Tobias_B_Huber) #Nephpearls #RKDSummit 👉🏼 pubmed.ncbi.nlm.nih.gov/4138…
Image from Edgar V. Lerma 🇵🇭 (@edgarvlermamd)
1
41
85
4,550
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Sanjeev Sethi (@SethiRenalPath) profile picture
Sanjeev Sethi
@SethiRenalPathSep 26
Tough case. LM: granulomatous interstitial nephritis, extensive. IF: negative. Look carefully and you start seeing small foci of necrosis in glomeruli, surrounded by inflammation/rupture of Bowman’s capsule. Dx: 1. Granulomatous interstitial nephritis. 2. Necrotizing glomerulonephritis, pauci-immune. (both possibly drug related). 30-yr woman with rash, serum creatinine 10, bipolar disorder-just started treatment. ANCA, other serology negative.
Image from Sanjeev Sethi (@SethiRenalPath)
Image from Sanjeev Sethi (@SethiRenalPath)
Image from Sanjeev Sethi (@SethiRenalPath)
Image from Sanjeev Sethi (@SethiRenalPath)
3
27
86
5,120
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Roger Rodby (@NephRodby) profile picture
Roger Rodby@NephRodbySep 18
I could add 10 more to the list Besides being the most common GN in the world, IgAN is the most heterogeneous glomerulopathy both histopathologically and clinically.
Abdelhamed Hamdy (@Abdelhamed012) profile pictureAbdelhamed Hamdy@Abdelhamed012Sep 17
IgA on biopsy
Image from Abdelhamed Hamdy (@Abdelhamed012)
1
8
1
32
2,771
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Roger Rodby (@NephRodby) profile picture
Roger Rodby@NephRodbySep 17
Starts in 90 minutes (1 PM CST). Join us and vote on your thoughts about the diagnosis and treatment! @TWhittier_RUSH will offer some teaching on the case.
Roger Rodby (@NephRodby) profile pictureRoger Rodby@NephRodbySep 16
We are finally back! Please join us TOMORROW 9/17/26 at 1 PM CST for a LIVE @Rush_Nephrology renal biopsy conference. This is a disease for which there is no standard of care. That's my story and I'm sticking to it! #RushRenalRules
Image from Roger Rodby (@NephRodby)
1
4
16
1,743
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Izabela Zakrocka (@IzabelaZakrocka) profile picture
Izabela Zakrocka@IzabelaZakrockaSep 17
Severe IgA nephropathy and drug’s effect? Here you go! Thank you as always ✨ @NephRodby @TWhittier_RUSH @Proximal_Baxi @BajinderR @Rush_Nephrology @Nephronpower
Image from Izabela Zakrocka (@IzabelaZakrocka)
Image from Izabela Zakrocka (@IzabelaZakrocka)
Image from Izabela Zakrocka (@IzabelaZakrocka)
Image from Izabela Zakrocka (@IzabelaZakrocka)
1
5
17
777
Load more